0001209191-17-025160.txt : 20170404 0001209191-17-025160.hdr.sgml : 20170404 20170404173355 ACCESSION NUMBER: 0001209191-17-025160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170401 FILED AS OF DATE: 20170404 DATE AS OF CHANGE: 20170404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AmpliPhi Biosciences Corp CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3579 VALLEY CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 804-827-2524 MAIL ADDRESS: STREET 1: 3579 VALLEY CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Salka Michael Scott CENTRAL INDEX KEY: 0001542981 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37544 FILM NUMBER: 17739848 MAIL ADDRESS: STREET 1: PO BOX 3577 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067-3577 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-01 0 0000921114 AmpliPhi Biosciences Corp APHB 0001542981 Salka Michael Scott 3579 VALLEY CENTRE DRIVE SUITE 100 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 0.43 2017-04-01 4 A 0 214214 0.00 A 2021-03-31 Common Stock 214214 214214 D The shares subject to the option are 100% vested and exercisable as of the date of grant. /s/ Steve R. Martin, Attorney-in-Fact 2017-04-04